VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Amifostine reduces gastro-intestinal toxicity after autologous transplantation for multiple myeloma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Amifostine reduces gastro-intestinal toxicity after autologous transplantation for multiple myeloma.
Amifostine reduces gastro-intestinal toxicity after autologous transplantation for multiple myeloma. Leuk Lymphoma. 2018 08; 59(8):1905-1912.
View in:
PubMed
subject areas
Adult
Aged
Amifostine
Case-Control Studies
Combined Modality Therapy
Diarrhea
Disease-Free Survival
Female
Gastrointestinal Diseases
Hematopoietic Stem Cell Transplantation
Humans
Male
Melphalan
Middle Aged
Multiple Myeloma
Nausea
Transplantation, Autologous
Vomiting
authors with profiles
RICHARD E CHAMPLIN
GABRIELA RONDON
MUZAFFAR H QAZILBASH
QAISER BASHIR